biologics

3rd Annual Computational Drug Development (CDD) for Biologics Summit

https://pharmaphorum.com/events/3rd-annual-computational-drug-development-cdd-for-biologics-summit/

WuXi to build new $60m clinical and manufacturing plant

https://pharmaphorum.com/news/wuxi-new-clinical-manufacturing-plant/

https://pharmaphorum.com/events/biosimilars-biologics-2018/

Attendee list for Biosimilars North America 2017 released

https://pharmaphorum.com/partner-content-market-access/attendee-list-for-biosimilars-north-america-2017-released/

Janssen invests $350m in new European biologics production

https://pharmaphorum.com/news/janssen-invests-350m-new-european-biologics-production/

CDD for Biologics Summit 2017

https://pharmaphorum.com/events/cdd-for-biologics-summit-2017/

20/06/2017

Disruption and maturity: the future directions for biologics

https://pharmaphorum.com/debates-insight-market-access/disruption-maturity-future-directions-biologics/

Regeneron to develop long release Eylea successor

https://pharmaphorum.com/news/regeneron-looks-sustained-release-eye-drug/

https://pharmaphorum.com/views-and-analysis/healthcare-systems-aren-t-making-the-most-of-biosimilars-pharma-needs-to-support-them/

Close in 10 seconds

Pharmaphorum.com

Search